HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Al-Lawati, A. A.M. Articles by Valliathu, J. Search for Related Content PubMed PubMed Citation Articles by Al-Lawati, A. A.M. Articles by Valliathu, J. Related Collections Valve disease

Eur J Cardiothorac Surg 2002;22:223-227
© 2002 Elsevier Science NL

Pregnancy and mechanical heart valves replacement; dilemma of anticoagulation

Cardiothoracic Surgery Unit, Royal Hospital Muscat, Sultanate of Oman, PO Box 225, Code 115, Muscat, Oman

Received 4 February 2002; received in revised form 13 May 2002; accepted 20 May 2002.

* Corresponding author. Tel.: +968-605-721; fax: +968-694-120
e-mail: adilawati{at}yahoo.com

Objectives: To establish a uniform anticoagulation regimen for pregnant patients with mechanical heart valves taking into account the socio-economic background and to evaluate the incidence of anticoagulant related complications. Methods: A retrospective study on 63 pregnancies in 21 women with mechanical heart valves was evaluated. These pregnancies were divided into two groups: Group I (n=42) received oral anticoagulants throughout pregnancy and Group II (n=21) received subcutaneous heparin in the 1st trimester and oral anticoagulants for the rest of pregnancy period. Both groups received heparin at time of delivery. Results: There was no case of coumarin embryopathy seen and there was no maternal death. Life threatening valve thrombosis occurred in two patients who were both from Group II and needed emergency re-replacement. Group I had a higher incidence of spontaneous abortion than Group II although this was not statistically significant. Conclusions: The role of coumarin embryopathy has been overstated. We recommend the use of oral anticoagulants throughout pregnancy especially in countries with similar socio-economic background.

Key Words: Mechanical heart valves • Coumarin embryopathy • Anticoagulation • Low molecular weight heparin

This article has been cited by other articles:

				S. M. Bates, I. A. Greer, I. Pabinger, S. Sofaer, and J. Hirsh Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 844S - 886S. [Abstract] [Full Text] [PDF]

				R. P Akhtar, A. R Abid, H. Zafar, M. A Cheema, and J. S Khan Anticoagulation in Pregnancy with Mechanical Heart Valves: 10-Year Experience Asian Cardiovasc Thorac Ann, December 1, 2007; 15(6): 497 - 501. [Abstract] [Full Text] [PDF]

				M. A Geelani, S. Singh, A. Verma, A. Nagesh, V. Betigeri, and M. Nigam Anticoagulation in Patients with Mechanical Valves During Pregnancy Asian Cardiovasc Thorac Ann, March 1, 2005; 13(1): 30 - 33. [Abstract] [Full Text] [PDF]